Validation study for anti-metabolic syndrome effect and intestinal functions in healthy Japanese adults: a double-blind randomized controlled trial

Validation study for anti-metabolic syndrome effect and intestinal functions in healthy Japanese adults: a double-blind randomized controlled trial - Validation study for anti-metabolic syndrome effect and intestinal functions in healthy Japanese adults

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017943

Enrollment

Registered

2015-06-17

Start date

2015-06-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Period: 12 week Test food: Marine origin extract Dose: three times a day (1 g for once time) Usage: ingestion of the test food along with the water or hot water after the meal Period: 12 week Te

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adults 2. BMI (25 kg/m2 to less than 30 kg/m2) 3. Defecation (2~5 times/week)

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Currently taking medicines, herbal medicines 4. Taking laver seaweed, sea alga, yogurt, oligosaccharide or lactic acid bacteria more than four times a week. 5. Allergic to medicines or foods related to the test food of this trial 6. Usually taking supplements or nutrient function foods in daily 7. Pregnant, lactating, or planning to get pregnant during the trial period 8. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial 9. Judged unsuitable for participating in this trial by physician

Design outcomes

Primary

Measure	Time frame
Body fat rate Serum lipid detailed fraction	—

Secondary

Measure	Time frame
Intestinal bacterial flora Blood test CAS-MT Bristol stool scale	—

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO, Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026